• Le 30 April 2019

For the third consecutive year, Philippe Moreau, university professor and hospital practitioner, director of the Integrated Cancer Research Site (SIRIC) and haematologist specialized in the treatment of multiple myeloma, is among the top 1% of the world’s leading researchers most cited across all fields of research, according to the prestigious Clarivate Analytics Report.

Philippe MoreauThis ranking of 6000 researchers - 157 of which are affiliated with a French institution - is based on an analysis of the number of times a scientific publication is cited or named in other publications, bearing in mind that a publication’s influence grows in line with the number of times it is cited. Philippe Moreau’s expertise is internationally recognized and he is particularly known for his clinical research studies that have helped to develop new treatments for patients with multiple myeloma.

This distinction is also an opportunity to highlight Nantes’ excellence in research in the field of blood diseases, especially Mature B-cell haematology, which has been carried out for over a decade by teams from Inserm and the Haematology department.